Year All202620252024202320222021202020192018201720162015201420122011 Sep 13, 2018 Ardelyx Submits New Drug Application for U.S. Marketing Authorization of Tenapanor for IBS-C to U.S. Food and Drug Administration Aug 29, 2018 Ardelyx Announces Science Translational Medicine Publication Detailing Tenapanor's Unique Mechanism of Action Inhibiting Paracellular Phosphate Absorption Aug 7, 2018 Ardelyx Reports Second Quarter 2018 Financial Results and Recent Highlights Aug 1, 2018 Ardelyx Announces Date of Second Quarter 2018 Financial Results and Conference Call May 29, 2018 Ardelyx to Present at the Jefferies 2018 Global Healthcare Conference May 22, 2018 Ardelyx Announces Pricing of Public Offering of Common Stock May 21, 2018 Ardelyx Raises $50 Million in Loan Agreement with Solar Capital and Bridge Bank May 21, 2018 Ardelyx Announces Proposed Public Offering of Common Stock May 8, 2018 Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights Mar 19, 2018 Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada